---
figid: PMC4128256__nihms610025f7
figtitle: Models of Ras signaling in NF1-deficient GBM cell lines
organisms:
- Homo sapiens
- Mus musculus
- Moloney murine leukemia virus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC4128256
filename: nihms610025f7.jpg
figlink: /pmc/articles/PMC4128256/figure/F7/
number: F7
caption: Models of Ras signaling in NF1-deficient GBM cell lines. A, NF1-deficient,
  MEK inhibitor–sensitive GBM signal through the RAF/MEK/ERK pathway. MEK/ERK inhibition
  by PD0325901 alone decreases cyclin D1 levels and cell growth. B, NF1-deficient,
  MEK inhibitor– resistant GBM signal through both RAF/MEK/ERK and PI3K/mTOR pathways.
  Both PD0325901 and PI-103 are required to decrease cyclin D1 levels. C, NF1-deficient,
  MEK inhibitor–resistant GBM signal through both the RAF/MEK/ERK and PI3K/mTOR pathways
  but ERK cross-talks with the mTOR pathway. PD0325901 and PI-103 may be required
  to decrease mTOR-regulated translation of cyclin D1.
papertitle: Sensitivity of Glioblastomas to Clinically Available MEK Inhibitors Is
  Defined by Neurofibromin 1 Deficiency.
reftext: Wendy L. See, et al. Cancer Res. ;72(13):3350-3359.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9372031
figid_alias: PMC4128256__F7
figtype: Figure
redirect_from: /figures/PMC4128256__F7
ndex: 6b328414-df03-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4128256__nihms610025f7.html
  '@type': Dataset
  description: Models of Ras signaling in NF1-deficient GBM cell lines. A, NF1-deficient,
    MEK inhibitor–sensitive GBM signal through the RAF/MEK/ERK pathway. MEK/ERK inhibition
    by PD0325901 alone decreases cyclin D1 levels and cell growth. B, NF1-deficient,
    MEK inhibitor– resistant GBM signal through both RAF/MEK/ERK and PI3K/mTOR pathways.
    Both PD0325901 and PI-103 are required to decrease cyclin D1 levels. C, NF1-deficient,
    MEK inhibitor–resistant GBM signal through both the RAF/MEK/ERK and PI3K/mTOR
    pathways but ERK cross-talks with the mTOR pathway. PD0325901 and PI-103 may be
    required to decrease mTOR-regulated translation of cyclin D1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Hras
  - Kras
  - Rem1
  - Nf1
  - te
  - Pten
  - Akt1
  - Zhx2
  - Pik3r1
  - Mdk
  - Mtor
  - Ie
  - KRAS
  - HRAS
  - NRAS
  - NF1
  - PTEN
  - AKT1
  - AKT2
  - AKT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - Ras64B
  - Ras85D
  - Akt
  - Raf
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Dsor1
  - Mtk
  - Tor
  - PD0325901
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
